Press Release, 12 May 2023
Realheart's recently published decision to communicate only in English is reversed. Shareholders and other stakeholders have provided feedback and emphasized the value of having communication in Swedish.
Based on this, Realheart chooses to return to communicating in both languages, as the company wants to meet the needs and wishes of the market. This means that all press releases and reports will continue to be published in both Swedish and English.
For more information please contact:
Ina Laura Perkins, CEO
Phone: +46(0)70 406 49 21
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart® TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation. A unique concept in the medical technology world.Realheart Returns to Communicating in Both Swedish and English (PDF)